Fovea-Sparing Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
Purpose To investigate the effectiveness and safety of a new surgical technique of fovea-sparing internal limiting membrane (ILM) peeling for the treatment of foveal retinal detachments (RDs) in eyes with myopic traction maculopathy. Design Retrospective, consecutive, interventional case series. Met...
Gespeichert in:
| Veröffentlicht in: | American journal of ophthalmology 2012-10, Vol.154 (4), p.693-701 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 701 |
|---|---|
| container_issue | 4 |
| container_start_page | 693 |
| container_title | American journal of ophthalmology |
| container_volume | 154 |
| creator | Shimada, Noriaki Sugamoto, Yoshiharu Ogawa, Manabu Takase, Hiroshi Ohno-Matsui, Kyoko |
| description | Purpose To investigate the effectiveness and safety of a new surgical technique of fovea-sparing internal limiting membrane (ILM) peeling for the treatment of foveal retinal detachments (RDs) in eyes with myopic traction maculopathy. Design Retrospective, consecutive, interventional case series. Methods Forty-five eyes of 45 consecutive patients who underwent vitrectomy and ILM peeling for the treatment of a foveal RD attributable to myopic traction maculopathy were studied. The patients were divided into 2 groups by the area of ILM peeled: complete macular ILM peeled group (30 eyes) and fovea-sparing ILM peeled group (15 eyes). A gas tamponade was used in all of the eyes. The main outcome measures were the rate of development of a full-thickness macular hole (MH) and the best-corrected visual acuity (BCVA). All of the patients were followed for more than 6 months. Results A full-thickness MH developed in 5 of 30 eyes (16.7%) in the complete ILM peeled group and in none of the 15 eyes in the fovea-sparing ILM peeled group. Postoperative OCT examination showed a contraction of the residual ILM on the fovea and reduction of the outer lamellar holes in the fovea-sparing ILM peeled group. The postoperative BCVA was significantly better than the preoperative BCVA in the fovea-sparing ILM peeled group ( P = .04), but not in the complete ILM peeled group. Conclusions Fovea-sparing ILM peeling results in better visual and anatomic outcomes for the treatment of foveal RD attributable to myopic traction maculopathy. These were accomplished by reducing the development of a full-thickness MH. |
| doi_str_mv | 10.1016/j.ajo.2012.04.013 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1069206094</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002939412003236</els_id><sourcerecordid>2779588851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-3ea56321b6cb79d525d6d1ec9bbac26100bfabd13b2b7fbcfc273d6c4acefdb33</originalsourceid><addsrcrecordid>eNp9kl-L1DAUxYMo7rj6AXyRggi-tOZPk7YIgiyuLszgwq7PIbm91dS2mU3ahfn2pszowj74FHL5nZt7Ti4hrxktGGXqQ1-Y3hecMl7QsqBMPCEbVldNzuqGPSUbSinPG9GUZ-RFjH26qqqsnpMzzmshJZMbcn3p79HkN3sT3PQzu5pmDJMZsq0b3bxWdjjaYCbMrhGHtdD5kO0Ofu8guw0GZuenbGdgGfzezL8OL8mzzgwRX53Oc_Lj8svtxbd8-_3r1cXnbQ5S8DkXaKQSnFkFtmpayWWrWobQWGuAK0ap7YxtmbDcVp2FDnglWgWlAexaK8Q5eX_suw_-bsE469FFwGFIs_olakZVw6miTZnQt4_Q3i-ry5WquaxpI2Si2JGC4GMM2Ol9cKMJhwTpNW7d6xS3XuPWtNQp7qR5c-q82BHbf4q_-Sbg3QkwEczQpSTBxQdOlcmrXLmPRw5TZPcOg47gcAJsXUCYdevdf8f49EgN6atcevA3HjA-uNUxafTNuhfrWjBOqeBCiT_DOLHo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1082580935</pqid></control><display><type>article</type><title>Fovea-Sparing Internal Limiting Membrane Peeling for Myopic Traction Maculopathy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shimada, Noriaki ; Sugamoto, Yoshiharu ; Ogawa, Manabu ; Takase, Hiroshi ; Ohno-Matsui, Kyoko</creator><creatorcontrib>Shimada, Noriaki ; Sugamoto, Yoshiharu ; Ogawa, Manabu ; Takase, Hiroshi ; Ohno-Matsui, Kyoko</creatorcontrib><description>Purpose To investigate the effectiveness and safety of a new surgical technique of fovea-sparing internal limiting membrane (ILM) peeling for the treatment of foveal retinal detachments (RDs) in eyes with myopic traction maculopathy. Design Retrospective, consecutive, interventional case series. Methods Forty-five eyes of 45 consecutive patients who underwent vitrectomy and ILM peeling for the treatment of a foveal RD attributable to myopic traction maculopathy were studied. The patients were divided into 2 groups by the area of ILM peeled: complete macular ILM peeled group (30 eyes) and fovea-sparing ILM peeled group (15 eyes). A gas tamponade was used in all of the eyes. The main outcome measures were the rate of development of a full-thickness macular hole (MH) and the best-corrected visual acuity (BCVA). All of the patients were followed for more than 6 months. Results A full-thickness MH developed in 5 of 30 eyes (16.7%) in the complete ILM peeled group and in none of the 15 eyes in the fovea-sparing ILM peeled group. Postoperative OCT examination showed a contraction of the residual ILM on the fovea and reduction of the outer lamellar holes in the fovea-sparing ILM peeled group. The postoperative BCVA was significantly better than the preoperative BCVA in the fovea-sparing ILM peeled group ( P = .04), but not in the complete ILM peeled group. Conclusions Fovea-sparing ILM peeling results in better visual and anatomic outcomes for the treatment of foveal RD attributable to myopic traction maculopathy. These were accomplished by reducing the development of a full-thickness MH.</description><identifier>ISSN: 0002-9394</identifier><identifier>EISSN: 1879-1891</identifier><identifier>DOI: 10.1016/j.ajo.2012.04.013</identifier><identifier>PMID: 22835515</identifier><identifier>CODEN: AJOPAA</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Aged ; Basement Membrane - pathology ; Basement Membrane - surgery ; Biological and medical sciences ; Coloring Agents ; Diabetic retinopathy ; Endotamponade ; Eyes & eyesight ; Female ; Humans ; Indocyanine Green ; Macular degeneration ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; Myopia ; Myopia, Degenerative - complications ; Myopia, Degenerative - physiopathology ; Myopia, Degenerative - surgery ; Ophthalmology ; Postoperative Complications ; Prone Position ; Retinal Detachment - etiology ; Retinal Detachment - physiopathology ; Retinal Detachment - surgery ; Retinal Perforations - etiology ; Retinopathies ; Retrospective Studies ; Staining and Labeling ; Standard deviation ; Sulfur Hexafluoride - administration & dosage ; Surgery ; Treatment Outcome ; Vision disorders ; Visual Acuity - physiology ; Vitrectomy</subject><ispartof>American journal of ophthalmology, 2012-10, Vol.154 (4), p.693-701</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-3ea56321b6cb79d525d6d1ec9bbac26100bfabd13b2b7fbcfc273d6c4acefdb33</citedby><cites>FETCH-LOGICAL-c532t-3ea56321b6cb79d525d6d1ec9bbac26100bfabd13b2b7fbcfc273d6c4acefdb33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002939412003236$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26426155$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22835515$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shimada, Noriaki</creatorcontrib><creatorcontrib>Sugamoto, Yoshiharu</creatorcontrib><creatorcontrib>Ogawa, Manabu</creatorcontrib><creatorcontrib>Takase, Hiroshi</creatorcontrib><creatorcontrib>Ohno-Matsui, Kyoko</creatorcontrib><title>Fovea-Sparing Internal Limiting Membrane Peeling for Myopic Traction Maculopathy</title><title>American journal of ophthalmology</title><addtitle>Am J Ophthalmol</addtitle><description>Purpose To investigate the effectiveness and safety of a new surgical technique of fovea-sparing internal limiting membrane (ILM) peeling for the treatment of foveal retinal detachments (RDs) in eyes with myopic traction maculopathy. Design Retrospective, consecutive, interventional case series. Methods Forty-five eyes of 45 consecutive patients who underwent vitrectomy and ILM peeling for the treatment of a foveal RD attributable to myopic traction maculopathy were studied. The patients were divided into 2 groups by the area of ILM peeled: complete macular ILM peeled group (30 eyes) and fovea-sparing ILM peeled group (15 eyes). A gas tamponade was used in all of the eyes. The main outcome measures were the rate of development of a full-thickness macular hole (MH) and the best-corrected visual acuity (BCVA). All of the patients were followed for more than 6 months. Results A full-thickness MH developed in 5 of 30 eyes (16.7%) in the complete ILM peeled group and in none of the 15 eyes in the fovea-sparing ILM peeled group. Postoperative OCT examination showed a contraction of the residual ILM on the fovea and reduction of the outer lamellar holes in the fovea-sparing ILM peeled group. The postoperative BCVA was significantly better than the preoperative BCVA in the fovea-sparing ILM peeled group ( P = .04), but not in the complete ILM peeled group. Conclusions Fovea-sparing ILM peeling results in better visual and anatomic outcomes for the treatment of foveal RD attributable to myopic traction maculopathy. These were accomplished by reducing the development of a full-thickness MH.</description><subject>Adult</subject><subject>Aged</subject><subject>Basement Membrane - pathology</subject><subject>Basement Membrane - surgery</subject><subject>Biological and medical sciences</subject><subject>Coloring Agents</subject><subject>Diabetic retinopathy</subject><subject>Endotamponade</subject><subject>Eyes & eyesight</subject><subject>Female</subject><subject>Humans</subject><subject>Indocyanine Green</subject><subject>Macular degeneration</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Myopia</subject><subject>Myopia, Degenerative - complications</subject><subject>Myopia, Degenerative - physiopathology</subject><subject>Myopia, Degenerative - surgery</subject><subject>Ophthalmology</subject><subject>Postoperative Complications</subject><subject>Prone Position</subject><subject>Retinal Detachment - etiology</subject><subject>Retinal Detachment - physiopathology</subject><subject>Retinal Detachment - surgery</subject><subject>Retinal Perforations - etiology</subject><subject>Retinopathies</subject><subject>Retrospective Studies</subject><subject>Staining and Labeling</subject><subject>Standard deviation</subject><subject>Sulfur Hexafluoride - administration & dosage</subject><subject>Surgery</subject><subject>Treatment Outcome</subject><subject>Vision disorders</subject><subject>Visual Acuity - physiology</subject><subject>Vitrectomy</subject><issn>0002-9394</issn><issn>1879-1891</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kl-L1DAUxYMo7rj6AXyRggi-tOZPk7YIgiyuLszgwq7PIbm91dS2mU3ahfn2pszowj74FHL5nZt7Ti4hrxktGGXqQ1-Y3hecMl7QsqBMPCEbVldNzuqGPSUbSinPG9GUZ-RFjH26qqqsnpMzzmshJZMbcn3p79HkN3sT3PQzu5pmDJMZsq0b3bxWdjjaYCbMrhGHtdD5kO0Ofu8guw0GZuenbGdgGfzezL8OL8mzzgwRX53Oc_Lj8svtxbd8-_3r1cXnbQ5S8DkXaKQSnFkFtmpayWWrWobQWGuAK0ap7YxtmbDcVp2FDnglWgWlAexaK8Q5eX_suw_-bsE469FFwGFIs_olakZVw6miTZnQt4_Q3i-ry5WquaxpI2Si2JGC4GMM2Ol9cKMJhwTpNW7d6xS3XuPWtNQp7qR5c-q82BHbf4q_-Sbg3QkwEczQpSTBxQdOlcmrXLmPRw5TZPcOg47gcAJsXUCYdevdf8f49EgN6atcevA3HjA-uNUxafTNuhfrWjBOqeBCiT_DOLHo</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Shimada, Noriaki</creator><creator>Sugamoto, Yoshiharu</creator><creator>Ogawa, Manabu</creator><creator>Takase, Hiroshi</creator><creator>Ohno-Matsui, Kyoko</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20121001</creationdate><title>Fovea-Sparing Internal Limiting Membrane Peeling for Myopic Traction Maculopathy</title><author>Shimada, Noriaki ; Sugamoto, Yoshiharu ; Ogawa, Manabu ; Takase, Hiroshi ; Ohno-Matsui, Kyoko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-3ea56321b6cb79d525d6d1ec9bbac26100bfabd13b2b7fbcfc273d6c4acefdb33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Basement Membrane - pathology</topic><topic>Basement Membrane - surgery</topic><topic>Biological and medical sciences</topic><topic>Coloring Agents</topic><topic>Diabetic retinopathy</topic><topic>Endotamponade</topic><topic>Eyes & eyesight</topic><topic>Female</topic><topic>Humans</topic><topic>Indocyanine Green</topic><topic>Macular degeneration</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Myopia</topic><topic>Myopia, Degenerative - complications</topic><topic>Myopia, Degenerative - physiopathology</topic><topic>Myopia, Degenerative - surgery</topic><topic>Ophthalmology</topic><topic>Postoperative Complications</topic><topic>Prone Position</topic><topic>Retinal Detachment - etiology</topic><topic>Retinal Detachment - physiopathology</topic><topic>Retinal Detachment - surgery</topic><topic>Retinal Perforations - etiology</topic><topic>Retinopathies</topic><topic>Retrospective Studies</topic><topic>Staining and Labeling</topic><topic>Standard deviation</topic><topic>Sulfur Hexafluoride - administration & dosage</topic><topic>Surgery</topic><topic>Treatment Outcome</topic><topic>Vision disorders</topic><topic>Visual Acuity - physiology</topic><topic>Vitrectomy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shimada, Noriaki</creatorcontrib><creatorcontrib>Sugamoto, Yoshiharu</creatorcontrib><creatorcontrib>Ogawa, Manabu</creatorcontrib><creatorcontrib>Takase, Hiroshi</creatorcontrib><creatorcontrib>Ohno-Matsui, Kyoko</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shimada, Noriaki</au><au>Sugamoto, Yoshiharu</au><au>Ogawa, Manabu</au><au>Takase, Hiroshi</au><au>Ohno-Matsui, Kyoko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fovea-Sparing Internal Limiting Membrane Peeling for Myopic Traction Maculopathy</atitle><jtitle>American journal of ophthalmology</jtitle><addtitle>Am J Ophthalmol</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>154</volume><issue>4</issue><spage>693</spage><epage>701</epage><pages>693-701</pages><issn>0002-9394</issn><eissn>1879-1891</eissn><coden>AJOPAA</coden><abstract>Purpose To investigate the effectiveness and safety of a new surgical technique of fovea-sparing internal limiting membrane (ILM) peeling for the treatment of foveal retinal detachments (RDs) in eyes with myopic traction maculopathy. Design Retrospective, consecutive, interventional case series. Methods Forty-five eyes of 45 consecutive patients who underwent vitrectomy and ILM peeling for the treatment of a foveal RD attributable to myopic traction maculopathy were studied. The patients were divided into 2 groups by the area of ILM peeled: complete macular ILM peeled group (30 eyes) and fovea-sparing ILM peeled group (15 eyes). A gas tamponade was used in all of the eyes. The main outcome measures were the rate of development of a full-thickness macular hole (MH) and the best-corrected visual acuity (BCVA). All of the patients were followed for more than 6 months. Results A full-thickness MH developed in 5 of 30 eyes (16.7%) in the complete ILM peeled group and in none of the 15 eyes in the fovea-sparing ILM peeled group. Postoperative OCT examination showed a contraction of the residual ILM on the fovea and reduction of the outer lamellar holes in the fovea-sparing ILM peeled group. The postoperative BCVA was significantly better than the preoperative BCVA in the fovea-sparing ILM peeled group ( P = .04), but not in the complete ILM peeled group. Conclusions Fovea-sparing ILM peeling results in better visual and anatomic outcomes for the treatment of foveal RD attributable to myopic traction maculopathy. These were accomplished by reducing the development of a full-thickness MH.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>22835515</pmid><doi>10.1016/j.ajo.2012.04.013</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9394 |
| ispartof | American journal of ophthalmology, 2012-10, Vol.154 (4), p.693-701 |
| issn | 0002-9394 1879-1891 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1069206094 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Aged Basement Membrane - pathology Basement Membrane - surgery Biological and medical sciences Coloring Agents Diabetic retinopathy Endotamponade Eyes & eyesight Female Humans Indocyanine Green Macular degeneration Male Medical sciences Middle Aged Miscellaneous Myopia Myopia, Degenerative - complications Myopia, Degenerative - physiopathology Myopia, Degenerative - surgery Ophthalmology Postoperative Complications Prone Position Retinal Detachment - etiology Retinal Detachment - physiopathology Retinal Detachment - surgery Retinal Perforations - etiology Retinopathies Retrospective Studies Staining and Labeling Standard deviation Sulfur Hexafluoride - administration & dosage Surgery Treatment Outcome Vision disorders Visual Acuity - physiology Vitrectomy |
| title | Fovea-Sparing Internal Limiting Membrane Peeling for Myopic Traction Maculopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T03%3A46%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fovea-Sparing%20Internal%20Limiting%20Membrane%20Peeling%20for%20Myopic%20Traction%20Maculopathy&rft.jtitle=American%20journal%20of%20ophthalmology&rft.au=Shimada,%20Noriaki&rft.date=2012-10-01&rft.volume=154&rft.issue=4&rft.spage=693&rft.epage=701&rft.pages=693-701&rft.issn=0002-9394&rft.eissn=1879-1891&rft.coden=AJOPAA&rft_id=info:doi/10.1016/j.ajo.2012.04.013&rft_dat=%3Cproquest_cross%3E2779588851%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1082580935&rft_id=info:pmid/22835515&rft_els_id=S0002939412003236&rfr_iscdi=true |